Canterbury DHB



If a patient is likely to have a higher dose of glucocorticoids or be given prednisone for a longer period than indicated above, then measures should be initiated to try to prevent excessive bone loss. This also applies to cyclosporin and tacrolimus treatment.

About this Canterbury DHB document (5072):

Document Owner:

Sean Macpherson (see Who's Who)

Last Reviewed:

January 2019

Next Review:

January 2022


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5072